Full name
PHARMACON SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ - SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
78.10.Z - Employment placement and recruitment services
78.30.Z - Employment activities
86.90.E - Healthcare
96.09.Z - Individual service activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | -0,1 | 0,8 | 722 |
EBITDA | 0,6 | 0,1 | 1 | 920,4 |
Short time liabilities | 5,2 | 5 | 4,6 | -9,2 |
Equity capital | -0,6 | -0,7 | -0,2 | 75,9 |
Operating profit (EBIT) | 0,5 | -0 | 0,9 | 2382,8 |
Assets | 4,8 | 4,6 | 4,8 | 3,5 |
Net profit (loss) | 0,5 | -0,1 | 0,5 | 469,2 |
Cash | 0,3 | 0,1 | 0,2 | 47,1 |
Liabilities and provisions for liabilities | 5,3 | 5,3 | 5 | -7,1 |
Net income from sale | 30,6 | 26,3 | 27,2 | 3,2 |
Working assets | 4,3 | 4,1 | 4,2 | 1 |
Depreciation | 0,1 | 0,1 | 0,1 | -14,4 |
% | % | % | p.p. | |
Profitability of capital | -88,8 | 20,6 | -314,7 | -335,3 |
Equity capital to total assets | -11,9 | -15,4 | -3,6 | 11,8 |
Gross profit margin | 1,6 | -0,5 | 3 | 3,5 |
EBITDA Margin | 2 | 0,4 | 3,6 | 3,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 62 | 70 | 61 | -9 |
Current financial liquidity indicator | 0.8152952194213867 | 0.9011898636817932 | 0,1 | |
Net dept to EBITDA | 19.791933059692383 | -0.08431162685155869 | -19,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane